[Somatostatin analogue (octreotide)].
Sano
K
K
Division of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, University of Tokyo.
Makuuchi
M
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D017481:Receptors, Somatostatin; D013004:Somatostatin / Q000031:analogs & derivatives; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D017481:Receptors, Somatostatin; D013004:Somatostatin; D015282:Octreotide